AEZS

AEterna Zentaris Inc. News Headlines

$0.648
*  
0.0302
4.89%
Get AEZS Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading AEZS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Seeking Alpha's Biotech Weekly: Intercept Pops, Provenge's Prince Valeant, And More
1/30/2015 4:00:00 PM - Seeking Alpha


Why I'm Upgrading AEterna Zentaris On Valuation
1/27/2015 11:07:00 AM - Seeking Alpha


Biotech Weekly: A Few Rules And Regulations Affecting Biotech Investors
12/22/2014 12:57:00 PM - Seeking Alpha


Update: My Discussion With RedChip And Thoughts Going Forward
12/8/2014 9:08:00 AM - Seeking Alpha


Why I Still Remain Bearish On AEterna Zentaris
11/8/2014 8:21:00 AM - Seeking Alpha


Update: AEterna Zentaris Q3 2014 Earnings
11/6/2014 4:58:00 AM - Seeking Alpha


AEterna Zentaris: The Bear Case In Front Of The November 5th PDUFA
10/30/2014 9:24:00 AM - Seeking Alpha


Following Biotech Stocks After Price Declines Of Greater Than 50%
9/25/2014 4:03:00 PM - Seeking Alpha


AEterna Zentaris Has A Great Value Proposition - CEO David Dodd Explains Why
9/23/2014 10:19:00 AM - Seeking Alpha


Aeterna Zentaris: A Risk Worth Taking
9/9/2014 1:54:00 PM - Seeking Alpha


Basket Of Biotech Bargains To Buy And Hold
6/30/2014 4:23:00 PM - Seeking Alpha


Looking For Value Among Biotechs After Precipitous Declines In Stock Price
3/24/2014 12:26:00 PM - Seeking Alpha


Aeterna Zentaris: Mispriced $1 Biotech Stock With Limited Downside Risk And Big Upside Potential
12/12/2013 1:15:00 PM - Seeking Alpha


AEterna Zentaris: An Interesting Investment With Long-Term Growth Potential
8/20/2013 10:42:00 AM - Seeking Alpha


Rexahn's Oncology Platform Led By Its Akt-1 Inhibitor Challenges Big Pharma With Ground-Breaking Cancer Therapy
6/5/2013 5:53:00 AM - Seeking Alpha


Smaller Companies With Potential For Big Returns
5/16/2013 11:49:00 AM - Seeking Alpha


Follow The Crashing Biotechs: 4 Stocks Fresh From A Fall
3/20/2013 3:03:00 PM - Seeking Alpha


Stock Watch Wednesday, 20 March 2013
3/20/2013 9:04:00 AM - Seeking Alpha


Stock Watch Tuesday, 12 March 2013
3/12/2013 7:36:00 AM - Seeking Alpha


Stock Watch Wednesday, 6 March 2013
3/6/2013 9:43:00 AM - Seeking Alpha


Stock Watch Thursday, 21 February 2013
2/21/2013 8:51:00 AM - Seeking Alpha


Cancer Stocks To Watch
2/11/2013 11:39:00 AM - Seeking Alpha


4 Small Cap Biopharmas With Near-Term Catalysts
2/11/2013 8:34:00 AM - Seeking Alpha


Stock Watch Thursday, 7 February 2013
2/7/2013 8:14:00 AM - Seeking Alpha


Is Keryx Biopharmaceuticals A Good Buy At $9+ ?
1/31/2013 4:37:00 PM - Seeking Alpha